Agomab Raises $100 Million
- Oct 12, 2023
- 1 min read
Ghent, Belgium, October 11, 2023 (Business Wire) -- Agomab Therapeutics NV (‘Agomab’) today announced the closing of a $100 million (€94.9 million) Series C financing round led by Fidelity Management & Research Company, with participation from new investors EQT Life Sciences (EQT), Canaan, Dawn Biopharma, a platform controlled by KKR, and existing investors.
Read full article here.